Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Outcome of children developing grade III-IV aGVHD after allogeneic HSCT

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Giovanna Lucchini

Pronostic des enfants développant une GvHD aiguë de grade III-IV après une greffe allogénique de cellules souches hématopoïétiques

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogénique - Apparentée

Allogénique - Non apparentée

Allogénique - Haplo-identique

Investigateur principal

Giovanna Lucchini

Evaluation of Outcomes following Allogeneic HCT in Pediatric Patients with High-Risk AML

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Type de traitement

Investigateur principal

HSCT for Congenital Amegakaryocitic thrombopecytopenia (CAMT)

Closed Survey/Study

Bone marrow failure

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Clémence Aldebert

Greffe de cellules souches hématopoïétiques (HSCT) pour la thrombocytopénie amégacaryocytaire congénitale (CAMT)

Aplasie Médullaire

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Clémence Aldebert

CLL - Projects about PI, ibrutinib and venetoclax

Retrospective Studies

Chronic Lymphocytic Leukaemia (CLL)

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

Olivier Tournilhac, Michel van Gelder

LLC - Projets sur les inhibiteurs de la voie des PI, l'ibrutinib et le venetoclax

Études rétrospectives

Chronic Lymphocytic Leukaemia (CLL)

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

Olivier Tournilhac, Michel van Gelder

Central nervous system disorders following hematopoietic stem cell transplantation: a prospective observational study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP)

Non-interventional Prospective Studies

Complications: infectious

Complications: non-infectious

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Martin Schmidt-Hieber

A prospective outcome study on patients with profound combined immune deficiency (p-CID)

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

LATE COMPLICATIONS AFTER AUTOLOGOUS HSCT FOR AUTOIMMUNE DISEASES: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Autoimmune Diseases Working Party (ADWP)

Transplant Complications Working Party (TCWP)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Kirill Kirgizov

Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional approach across Europe (NISSC-2)

Non-interventional Prospective Studies

Autoimmune Diseases Working Party (ADWP)

Type de traitement

Investigateur principal

Pr Dominique Farge

Trend and outcome of HSCT in Thalassemia inside the EBMT

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Baronciani Donatella